Ukinuta odobrenja, povlačenje serija lijekova, pisma zdravstvenim radnicima i novi lijekovi EU — svakodnevno, automatski. Zadnje ažuriranje: 21. 11. 2026. 08:55
Izvori: promjene pratimo na temelju informacija Agencije za lijekove i medicinske proizvode (HALMED) — rješenja o ukidanju odobrenja, obavijesti o povlačenju serija i pisma zdravstvenim radnicima. Odluke o centralizirano odobrenim lijekovima dolaze iz registra Unije Europske komisije (oznaka EU). Nestašice i liste lijekova HZZO-a ovdje (još) nisu uključene.
br. EU/1/13/887 · odobreno 4. 12. 2013. · Prophylaxis of influenza in children and adolescents from 24 months to less than 18 years of age.
The use o… · AstraZeneca AB · influenza vaccine (live attenuated, nasal) · ATC J07BB03
br. EU/1/24/1879 · Prophylaxis of influenza in adults and children from 6 months of age.
Flucelvax should be used in accordan… · Seqirus Netherlands B.V. · influenza vaccine (surface antigen, inactivated, prepared in cell cultures) · ATC J07BB02
br. EU/1/24/1878 · Prophylaxis of influenza in adults 50 years of age and older.
Fluad should be used in accordance with offic… · Seqirus Netherlands B.V. · influenza vaccine (surface antigen, inactivated, adjuvanted) · ATC J07BB02
br. EU/1/24/1816 · Fluenz is indicated for active immunisation for the prevention of influenza disease in children and adolescent… · AstraZeneca AB · Influenza vaccine (live, nasal) · ATC J07BB03
br. EU/1/24/1806 · Celldemic is indicated for active immunisation against H5N1 subtype of Influenza A virus in adults and infants… · Seqirus Netherlands B.V. · Zoonotic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted, prepared in cell cultures) · ATC J07BB02